You are right Argus-II will give nice revs for next earnings call.
I was just stating that it will be into 2018 before we really get good feedback on Ist Orion surgery. I do not expect EYES to release any
Orion operation data results until the patient has time to adjust and provide insight to researchers.
I am also expecting .25-1.00+ price increase as public observes all types of info and discussions of what Orion means for worldwide visually impaired persons and the implications for AI and Robotics.
Blindness is one of most urgent medical conditions average person fears.
Any salvation from that potential medical state will be a big cause for celebration in Media and public awareness.
One has to really admire this company.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM